Immunomodulatory mechanisms include enhanced T-cell proliferation leading to the increased production of interleukin-2 (IL-2) and interferon-γ (IFN-γ), in addition to amplified natural killer (NK) cells activity and antibody-dependent cell-mediated cytotoxicity (ADCC) in MM cells [176]. This evidence concerns the gene IL2 and Miyoshi myopathy.